← 홈

Antibody · HER2+ 유방암 · HER2

93개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 93개
AntibodyAHotBristol Myers SquibbdeliveryPhase 3

Ipilimumab (Ipilimumab)

Advanced Hepatocellular Carcinoma (HCC) · HER2

#HER2#Antibody#Phase3#인기#항체+5
효능 ORR 75%임상시험 413상태 ACTIVE
AntibodyCHotRocheDM1) and trastuzumab deruxt…Phase 3

Pertuzumab (Pertuzumab)

Colorectal Cancer · HER2

#HER2#Antibody#Phase3#인기#항체+5
효능 ORR 91.8%임상시험 204상태 DISCONTINUED
AntibodyCInnoventvedotin (an HER2-targeted a…Phase 3

Sintilimab (Sintilimab)

Advanced Hepatocellular Carcinoma (HCC) · HER2

#HER2#Antibody#Phase3#인기#항체+5
임상시험 95상태 RECRUITING
AntibodyARochederuxtecan (Dato-DXd, Datro…Phase 3

Herceptin (Trastuzumab, Trastuzumab (Herceptin))

Breast Neoplasm, Exercise · HER2

#HER2#Antibody#Phase3#인기#항체+5
효능 ORR 91.2%임상시험 80상태 RECRUITING
AntibodyCJiangsu HengruiPhase 2

Camrelizumab (Camrelizumab)

Advanced Hepatocellular Carcinoma (HCC) · HER2

#HER2#Antibody#Phase2#인기#항체+5
임상시험 78상태 RECRUITING
AntibodyAkeso-drivenPhase 2

cadonilimab (cadonilimab)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#인기#항체+5
임상시험 65상태 RECRUITING
AntibodyAkesogovitecan), and chimeric an…Phase 2

Ivonescimab (Ivonescimab)

Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma · HER2

#HER2#Antibody#Phase2#인기#항체+5
임상시험 62상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Paclitaxel + Trastuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 69.3%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 4 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 84%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 8 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.3%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Trastuzumab+ chemotherapy)

HER2-positive Advanced Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 88.6%임상시험 31상태 RECRUITING
AntibodystaleJazz PharmaceuticalsPhase 2

Zanidatamab (ZW25, ZW25 (Zanidatamab))

HER2+/HR+ Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 34%임상시험 31상태 ACTIVE
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

AMG 479 (AMG 479, Ganitumab, AMG 479 (Ganitumab) plus Metformin)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 27%임상시험 30상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab plus Olaparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 55.1%임상시험 30상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, HER2, pyrotinib + pertuzumab/trastuzumab)

Salivary Gland Carcinoma; Precision Therapy · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 30상태 RECRUITING
AntibodystaleJazz PharmaceuticalsPhase 3

Zanidatamab (Zanidatamab)

HER2-positive Breast Cancer; Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
효능 ORR 34%임상시험 30상태 RECRUITING
AntibodystaleZhiyong YuPhase 2

Inetetamab (Inetetamab)

Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 26상태 ACTIVE
AntibodystaleRegeneronPhase 2

Cemiplimab plus REGN3767 (Cemiplimab plus REGN3767)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 23상태 RECRUITING
AntibodystaleRocheApproved

trastuzumab (Herceptin, Trastuzumab rezetecan)

HER2-positive Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+3
임상시험 19상태 RECRUITING

1 / 5 페이지

← 이전다음 →